实用老年医学 ›› 2026, Vol. 40 ›› Issue (2): 154-158.doi: 10.3969/j.issn.1003-9198.2026.02.010

• 临床研究 • 上一篇    下一篇

亚甲蓝复合罗哌卡因行髂筋膜阻滞用于老年髋关节置换术病人术后镇痛的半数有效剂量和不良反应分析

张扬, 杨顺, 陆咨儒, 沙荔荔   

  1. 225500 江苏省泰州市,泰州市姜堰中医院麻醉科(张扬,杨顺); 骨科(陆咨儒);
    225500 江苏省泰州市,扬州大学附属泰州第二人民医院麻醉科(沙荔荔)
  • 收稿日期:2025-07-08 出版日期:2026-02-20 发布日期:2026-02-27
  • 通讯作者: 沙荔荔,732809242@qq.com
  • 基金资助:
    江苏省泰州市科技支撑计划(社会发展)项目(SSF20230101)

Analysis of the median effective dose and adverse effects of methylene blue combined with ropivacaine for fascia iliaca compartment block in postoperative analgesia in elderly patients undergoing hip arthroplasty

ZHANG Yang, YANG Shun, LU Ziru, SHA Lili   

  1. Department of Anesthesiology (ZHANG Yang, YANG Shun); Department of Orthopedics (LU Ziru), Taizhou Jiangyan Hospital of TCM, Taizhou 225500, China;
    Department of Anesthesiology, Taizhou Second People’s Hospital Affiliated to Yangzhou University, Taizhou 225500, China (SHA Lili)
  • Received:2025-07-08 Online:2026-02-20 Published:2026-02-27
  • Contact: SHA Lili, Email:732809242@qq.com

摘要: 目的 测定亚甲蓝作为局麻药佐剂与罗哌卡因复合应用于老年髂筋膜阻滞在髋关节置换术病人术后24 h有效镇痛和不影响下肢肌力的半数有效剂量(ED50)及95%有效剂量(ED95),并观察病人术后24 h的不良反应。 方法 选取泰州市姜堰中医院2024年7—11月择期行全髋关节置换术的老年病人29例,在全麻诱导前行超声引导下髂筋膜阻滞,注射药液为不同剂量的亚甲蓝复合0.25%罗哌卡因共30 mL。首例病人使用亚甲蓝剂量为40 mg,使用Dixon序贯法确定下一例病人使用亚甲蓝的剂量,若前一例病人在术后24 h内出现股四头肌肌力≥4分,同时静息VAS评分≤1分,且活动时VAS评分≤3分,则下一例病人降低一个阶梯的亚甲蓝剂量,反之,增加一个阶梯剂量,直至出现7个交叉点时研究终止。采用Probit回归分析法计算亚甲蓝的ED50、ED95及其95%CI。同时观察髋关节置换术后24 h的不良反应。 结果 亚甲蓝复合罗哌卡因行髂筋膜阻滞在老年髋关节置换术后能有效镇痛且不影响下肢肌力的ED50为26.956 mg(95%CI:18.929~32.231 mg),ED95为40.070 mg(95%CI:33.878~84.708 mg)。髋关节置换术后24 h内,有2例病人需要额外使用镇痛药物,均出现在使用低于ED50剂量时。仅有1例病人出现下肢无力而无法下床走动,亚甲蓝的使用剂量为20 mg。没有病人因为术后肌无力而出现摔倒现象。所有病人均未出现神经损伤、穿刺点感染及药物中毒等神经阻滞并发症。 结论 亚甲蓝复合罗哌卡因行髂筋膜阻滞在老年髋关节置换术术后镇痛的ED50为26.956 mg,ED95为40.070 mg,同时,亚甲蓝没有增加罗哌卡因的运动阻滞风险,术后不良反应发生率低。   

关键词: 亚甲蓝, 髂筋膜阻滞, 髋关节置换, 老年人, 半数有效剂量, 95%有效剂量

Abstract: Objective To determine the median effective dose (ED50) and 95% effective dose (ED95) of methylene blue as an adjuvant to ropivacaine in elderly patients undergoing fascia iliaca compartment block for postoperative 24-hour effective analgesia without affecting lower limb muscle strength after hip replacement surgery, and to observe adverse reactions within 24 hours postoperatively. Methods A total of 29 patients scheduled for elective total hip arthroplasty in Taizhou Jiangyan Hospital of TCM from July to November 2024 were enrolled. Prior to general anesthesia induction, an ultrasound-guided fascia iliaca compartment block was performed using 30 mL of 0.25% ropivacaine combined with varying doses of methylene blue. The first patient received 40 mg of methylene blue, and subsequent doses were adjusted using Dixon’s up-and-down sequential method. If a patient achieved quadriceps muscle strength ≥4, resting VAS score ≤1, and movement VAS score ≤3 within 24 hours, the next patient received a lower dose; otherwise, the dose was increased. The study terminated after seven crossover points. Probit regression analysis was used to calculate the ED50, ED95, and their 95% confidence intervals. Adverse reactions within 24 hours postoperatively were recorded. Results The ED50 of methylene blue combined with ropivacaine for effective analgesia without motor block was 6.956 mg (95%CI:18.929-32.231 mg), and the ED95 was 0.070 mg (95%CI: 33.878-84.708 mg). Two patients required additional analgesics, both occurring at doses below the ED50. Only one case (20 mg methylene blue) experienced lower limb weakness preventing ambulation. No falls due to muscle weakness occurred. None of the patients developed nerve injury, puncture-site infection, drug toxicity, or other nerve block-related complications. Conclusions The ED50 of methylene blue combined with ropivacaine for postoperative analgesia via fascia iliaca compartment block in elderly hip arthroplasty was 26.956 mg, with an ED95 of 40.070 mg. Importantly, the addition of methylene blue did not potentiate the motor-blocking risk of ropivacaine, while maintaining a favorable safety profile with low incidence of postoperative adverse effects.    

Key words: methylene blue, iliac fascia block, hip replacement, aged, half-effective dose, 95% effective dose

中图分类号: